Observational studyJournal of endocrinological investigation2022

Graves' disease induced by Alemtuzumab in relapsing-remitting multiple sclerosis patients: an observational study in a reference center.

P Rodríguez de Vera Gómez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.